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The crystal structure of (—)-corycavinium (+)-10-camphorsulfonate has been investigated by X-ray analysis. 
The structure of (-)-corycavinium ion ( = (-)-(7S,l3S,\4R)-5,6,13,13a-tetrahydro-l3a-hydroxy-7-methyl-
2,3;9,10-bis(methylenedioxy)-8//-dibenzo[a,g]quinolizinium), has been determined. The conformation with B/C-
cis -conjunction, a twisted half-chair of ring B, and a half-chair of ring C, as well as a -oriented substituted groups 
N - M e , C • M e , and C - O H is revealed. Feeding experiments with cell suspension cultures of Corydalis incisa 
(Papaveraceae) defined the intermediacy of (—)-corycavinium in the route from protoberberine-type to hexa-
hydrobenzo[c]phenanthridine-type of alkaloids. On the basis of the present crystal conformation, the 
stereospecificity of the relating enzyme is biogenetically considered. 
Introduction. - Since 1867, there have been chemical studies [1] of protopine-type 
alkaloids, produced by all papaveraceae spp., with contemporary efforts focussed on this 
group's biosynthetical behavior [2-5]. Protopine-type alkaloids function as key interme-
diates in the metabolism of the protoberberine type (Scheme 1). 
The structural formulas of protopine-type alkaloids are commonly described as 'free 
base form (a)' in which ring B is a ten-membered ring with a tertiary N-atom. They are 
so-called, because this type of alkaloids are conventionally isolated under conditions of a 
strongly alkaline solution from an extract of papaveraceae plants. Though the chemically 
isolated form of this type alkaloid is the tertiary free-base form a, the quarternary form 
may be essential under the living-cell condition, the presence of free base form a being 
impossible in the cytoplasm of a plant cell, owing to its poor solubility. Three forms are 
possible structures for the quarternary form of protopine-type alkaloids; i.e., protonated 
type 'protonated form (b)', eis -ring-closure type 'protopinium form (ccis)\ and trans -ring-
closure type 'protopinium form (ctransy. 
Although use of spectroscopic methods such as C D , IR, and N M R has been proven 
for the conformational study of the tertiary-amine form of alkaloids, it is not so useful for 
the quarternary amine form, when it is the salt of protopine-type alkaloids. This problem 
may be due to the use of polar solvents in measuring the spectra of the structures 
possessing the ionic bonding. Consequently, while the importance of protopine-type 
alkaloids is now well known, studies involving the protopinium form, which give a 
well-defined conclusion, are limited to the use of X-ray analysis [6]. 
Scheme 1. The Biosynthetic Pathway from Protoberberine-Type via Protopine-Type 
to the Other Types in Papaveraceae 
Protoberberine type 
Free-base form (a) Protonated form (b) Protopinium form (c) 
Protopine type 
Benzo[c]phenanthridine type Spirobenzylisoquinoline type Benzindanoazepine type 
Our previous results in biosynthetic studies [4] [5] suggested that the O-containing 
functional group on the structure may play an important role in a C(6)—N(7), C(8)—N(7), 
and C(14)-N(7) bond cleavage for further metabolites in the pathway of protoberberine 
alkaloids. The accumulation of the steric molecular structure for salt forms of protopine-
type alkaloids, particularly at C(14)—N(7) moiety, may tell us what kind of enzymatic 
reaction mechanism is taking place at the ring-formation stage. 
The present investigation was undertaken by X-ray analysis to clarify the steric 
structure of (—)-corycavinium (lc) salt, which is one of the protopine-type alkaloids, and 
by means of feeding experiments to confirm this compound as a key intermediate to the 
hexahydrobenzo[c]phenanthridine-type alkaloids, (+)- and (—)- corynoline (2), and (+)-
14-epicorynoline (3), etc. 
Results and Discussion. - X-Ray Analysis. In solution or in solid state, the free base 
form a of (—)-corycavine (la) gives rise relatively easily to a racemate by epimerization of 
an asymmetric C-atom. This is because the atom is located in the 13 position adjacent to 
a C = 0 group in the structure [7-9]. This racemization of optically active corycavine (la) 
also arises, when common procedures are applied for its isolation from the plants. 
Consequently, to obtain 100% optically pure corycavine (la), it is necessary to employ an 
operation of purification by functional recrystallization of the diastereoisomeric salts 
with (+)-10-camphorsulfonic acid, and this salt form is useful for avoiding racemization. 
A perspective drawing with the numbering schemes of (—)-corycavinium (lc) (+)-10-
camphorsulfonate structure, obtained by X-ray crystal analysis, is shown in Fig. 1. 
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Fig. 1. Molecular structure of (—J-corycavinium ( + )-10-camphorsulfonate 
The corycavinium (lc) molecule is 5,6,13,13a-tetrahydro-l3a-hydroxy-7-methyl-
2,3;9,10-bis(methylenedioxy)-8/f-dibenzo[fl,^]quinolizinium. The basic carbocyclic 
structure of the salt form of corycavine is B/C ring-closed form, namely protopinium 
form c, consistent with the X-ray analysis of coulteropine hydrobromide [6]. 
The torsion angles along the B/C ring-junction axis N(7)—C(14) are shown in Fig. 2. It 
is noteworthy that the mode of B/C ring junction in corycavinium; i.e., the stereostruc-
ture of quinolizidine moiety, has been revealed as eis -configurated, protopinium form 
ccis, with the torsion angle CH 3 (21)-N(7)-C(14)-OH 64.7(6)°, whereas coulteropine 
hydrobromide has a trans-ring junction, protopinium form ctrans, with ca. 180°. The 
dihedral angle between the mean planes of aromatic rings A and D in the corycavinium 
molecule is 79.8(2)°. Compared with the angles of protoberberine alkaloids, this value is 
similar to those for capaurine hydrobromide [10] and capaurimine /7-bromobenzoate 
[11], i.e. 70.7° and 61.6°, respectively, which adopt eis -fused quinolizidine conformation, 
and differ greatly from the value 25.7° for canadinium camphorsulfonate [12], in which a 
trans -quinolizidine skeleton is involved. As for the reason why the crystal structure 
observed has a eis -quinolizidine system, but not trans, the following can be considered: in 
the corycavinium (lc) molecule, the cis-BjC-junction can be interpreted as a result of the 
relief of the steric repulsion due to the existence of the 'peri-interaction' between the 
bonds C(13)—C(22)H3 and C(15)—C(1)H, when the molecule adopts trans -junction. 
Further, it seems that the cis-B/C-quinolizidine conformation of corycavinium (lc) is 
more reasonable than the trans one, since (—)-corycavine (la) is chemically converted by 
ring closure into (—)-7V-methyl-m^ö-tetrahydrocorysaminium (4) salt, in which eis -fused 
quinolizidine has been presumed in the skeleton [8]. 
The ring B is in a half-chair conformation, and ring C is in a twisted half-chair 
conformation (Fig. 3). Ring B is much more distorted than ring C. Such a twisting might 
have occurred through moving away from the steric crowd caused by 1,3-diaxial inter-
action, both between bonds C(6)—H a x and C(13)—C(14), and between C(6)—H a x and 
C(8)-C(17). 
HO 52.8(6)C(8) 
( 15)C 62.3(6) C(*) 
Fig. 2. Torsion angles [°] with standard deviations about the bond N(7) —C( 14) 
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Fig. 3. Schematic projection of rings B and C. Deviations of atoms from the least-squares planes of aromatic ring. 
The thick bar stands for the aromatic ring, indicating ring A (a) and ring D (b). Deviations in Ä, with e.s.d.'s in 
parentheses. 
Bond lengths and angles appear to be similar to those of related compounds, 
except for the bond length of C(14)—N(7) atoms in corycavinium (lc). While the typical 
value for C - N + takes 1.52 Ä [13], this distance shows the value 1.583(8) Ä. This lengthen-
ing may be due to strain in the molecule, in which the C(14),N(7) ring closure is 
somewhat crowded. Particularly the steric factors around C(14) atom may affect the 
length. The order of the C — N + bond length of corycavinium (lc) camphorsulfonate 
(1.583 Ä) = coulteroine • HBr (1.58 Ä) < capaurimine • HBr (1.56 Ä) < canadinium 
camphorsulfonate (1.53 Ä) is proportional to the order of steric hindrance, 
H O ~ C(14)—N+—Me (B/C ring junction with angular O H and Me 
groups) > H - C ( 1 4 ) - N + - H (cis-B/C-ring junction) > H - C ( 1 4 ) - N + - H (trans-B/C-
ring junction). 
Fig. 1 depicts the absolute structure of the (—)-form corycavinium (lc) ion relative to 
the known absolute configuration of (+)-10-camphorsulfonate ion, the absolute configu-
ration of which is the same as that determined chemically and crystallographically for 
(+)-(li?,4Ä)-camphor [14]. Thus, it was proven that the absolute configuration of the 
(—)-corycavinium (lc) molecule is (1S,\3S,\4R). This agrees with our previous result 
based on the use of the C D spectral method [8]. 
The packing diagram of (—)-corycavinium (lc) (+)-10-camphorsulfonate is shown in 
Fig. 4. The shortest distance between anion and cation, 3.799(7) Ä, is found from N(7) to 
0(3c). The layers consisting of'(—)-corycavinium (lc) cations and of (4-)-10-camphorsul-
fonate anions are alternatively arranged parallel to the 6-axis. This packing state between 
the anion and cation molecules is similar to that in (—)-canadinium (+)-10-camphorsul-
fonate. 
Biosynthetic Studies. We report here on a biosynthetic investigation of corycavinium 
(lc) as a key intermediate in the route from protoberberine-type to hexahydrobenzo-
[c]phenanthridine-type alkaloids, an investigation using the callus tissues of Corydalis 
incisa (Papaveraceae). The callus tissues of C. incisa were derived from the stem tissue, 
and in the suspension cultures the substrates, 13C-labelled (±)-7V r-methyl-w^ö-tetrahy-
drocorysaminium (4) chloride and (±)-corycavinium (lc) chloride, were administered 
according to the previously described procedure [3]. In Table 7, the results of the feeding 
experiments are listed. 
Table 1. Incorporation Experiments with 13C-Labelled Substrates on the Tissue Cultures o /C . incisa 
Exper. Substrate Conversion yield of metabolic product [%] 
(-)-l (+)-2 (+)-3 
1 ( ± ) - 4 - C l 12.7 3.3 0.3 
2 ( ± ) - 4 - C l 15.4 trace trace 
3 (±)-lc 7.5 5.6 
4 (±)-lc 5.5 5.0 
Exper. 1 and 2 showed that (±)-A/-methyl-raesö-tetrahydrocorysaminium (4) salt was 
transformed to (—)-corycavine (la) with a 12.7% and 15.4% conversion yield, and to 
corynoline (2) with 3.3%. In spite of the use of the racemate form, the recovered 
substrates contained much (+)-enantiomer (optical purity ca. 88-95 %). This implies that 
only the levorotatory form can be stereospeciflcally metabolized into corycavine (la) and 
corynoline (2). 
In Exper. 3 and 4, corycavinium (lc) salt was transformed to corynoline (2) and 
14-epicorynoline (3) with a ca. 5-7% conversion yield. 
With these studies, the sequence (—)-N-methyl-raesö-tetrahydrocorysaminium (4) 
salt => (—)-corycavinium (lc) salt => corynoline (2) and 14-epicorynoline (3) has been 
described. It has also been determined that lc plays an important role in the metabolic 
route (Scheme 2). 
Scheme 2. Biogenetic Sequence in Tissue Cultures of Corydalis incisa 
4, (—)-A/-methyl-meso-
tetrahydrocorysaminium 
1c, (—)-corycavinium 2, (+)-corynoline: - " H 
3, (+)-14-epicorynoline:-^H 
Biosynthetic Implications of the Absolute Configuration and Molecular Conformation 
of (' —)-Corycavinium (lc). It is interesting to speculate about which molecule can 
stereospecifically interact as a substrate with the enzyme relating to the metabolism. 
Although there is no direct evidence of the interaction between the molecule and the 
enzyme, the results obtained by the present study would provide the following hypothe-
sis: a) The enzyme functions as a hydroxylase with levorotatory enantiomeric specificity 
in A^-methyl-m^ö-tetrahydrocorysaminium (4) salt metabolism, b) The enzyme intro-
duces the O H group at C(14) with the complete retention of the absolute configuration at 
both C(13) and C(14). c) After the introduction of the O H group at C(14), the cleavage of 
the bond C(6)—N(7) proceeds oxidatively. d) The process of the new bond formation 
between atoms C(6) and C(13) on the /?-side of the molecule is subjected to the conforma-
tionally steric hindrance among the a-oriented substituents, N ( 7 ) - M e , C(13) -Me , and 
C ( 1 4 ) - O H . 
Although further clarification of the biosynthetic mechanism of the alkaloids must be 
subjected to a future, detailed biosynthetic study, from the viewpoint of conformational 
investigation into the substrate side, the present study provides an efficient approach for 
a biogenetic study. 
Experimental Part 
General. M.p. : Yanagimoto microhotstage apparatus, uncorrected. Optical rotations: DIP-SL (Jasco) Polar-
imeter. IR Spectra: in K B r or CHC1 3 , with an EPI-C2 {Hitachi) spectrometer. ' H - N M R Spectra: in CDC1 3 or 
C D 3 O D soln. with T M S as an internal standard on a Varian-XL 200 (200 MHz) and a Varian VXR-500 (500 MHz) 
spectrometer. M S : Jeol-DIS spectrometer. 
X-Ray Analysis. Material. (±)-Corycavine (1) was isolated from Corydalis incisa and C. cava (Papaveraceae) in 
the usual way. (-)-Corycavinium (+)-10-camphorsulfonate was prepared according to [8], and single crystals for 
X-ray study were obtained from M e O H at r.t. 
Crystal-Structure Determination and Refinement. Crystal density was measured by the flotation method using 
a mixture solvent benzene/bromobenzene. Crystal data for (—)-corycavinium (+)-10-camphorsulfonate is pre-
sented in Table 2. 
Table 2. Crystal Data of (-)-Corycamnium ( + )-10-Camphorsulfonate 
Formula C 2 1 H 2 2 0 5 N + C 1 0 H 1 5 O 4 S -
M o l . wt. 599.71 
M.p. [°C] 282-287 (methanol) 
Crystal system orthorhombic 
Space group P2{l{lx 
Cell dimensions a = 8.294(2) Ä 
b = 11.625(3) Ä 
c = 29.096(8) Ä 
K[Ä 3] 2805(1) 
F(000) 1272 
A [A] 1.5418 
//[cm l] 14.77 
Z 4 
AJg-cm" 3] 1.420 
Dm[g-cm~3] 1.419 
No. of measured reflections 2746 
No. of unique reflections 2732 
No. of obs. reflections 2732 (including F0 = 0.0) 
R 0.067 
K 0.068 
The cell-dimensions and orientation matrix were calculated by the least-squares method from the angular 
values of 25 reflections collected with an AFC-5 diffractometer (Rigaku Co., Ltd.). The intensities were collected 
with an co-29 scan mode. The intensities of 4 standard reflections, measured every 100 reflections, remained 
constant within ± 1% of their mean values. The measured intensities within 26 = 130° were then subjected to 
Lorentz and polarization corrections; absorption correction was also applied, based on the intensity variation of a 
(OfcO) reflection for the 0 scan a t / = 90°. The structure was solved by direct methods using the M U L T A N Program 
System [15] and refined by the full-matrix least-squares method with isotropic thermal parameters, and then by the 
block-diagonal least-squares method with anisotropic ones. The H-atom positions were located from a subsequent 
difference Fourier map. The function minimized was Z(\F0\ — \FC\)2 and the discrepancy index R was 0.067; S 
(= [(w\F0\ — \FC\)2/(M — N)]y\ where M — No. of observed reflections and N = No. of variables) was 1.777. None 
of the positional parameters shifted more than one-fifth of their standard deviation, and maximum electron density 
in the final Fourier synthesis was 0.23 e - Ä - 3 . For all crystallographic computations, the U N I C S programs [16] 
were used, and atomic scattering factors were from International Tables for X-Ray Crystallography [17]. A l l 
numerical calculations were carried out on an ACOS-2020 computer at the Computation Center of Osaka 
University and on a Micro VAX II computer at Osaka University of Pharmaceutical Sciences. 
Callus Culture. The callus were derived in February 1975 from the stem of Corydalis incisa on Murashige and 
Skoog's medium containing (2,4-dichlorophenoxy)acetic acid (1 mg/1), kinetin (0.1 mg/1), yeast extract (0.1 %), and 
agar (1.2%). The callus tissues were subcultured in the dark every 3 weeks onto the fresh medium at 22°. 
Preparation of (±J-N-//13 C) Methyl]-mQSO-tetrahydrocorysaminium (4) Chloride (4-CI). To an acetone 
soln. (30 ml) of coptisine chloride (1 g), isolated from Chelidonium majus (Papaveraceae), aq. N a O H soln. (10%, 12 
ml) was added, and the mixture was shaken at r.t. for 0.5 h. The acetone layer was separated by a separatory funnel, 
and evaporated in vacuo to give coptisine-acetone adduct (940 mg) as a yellow crystalline solid. To a soln. of 
coptisine-acetone adduct (1 g), M e l (5 ml) was added, and the mixture was kept at 50° for 4.5 h in a sealed tube. 
After cooling, the precipitated crystals (corysaminium iodide 220 mg) were filtered. The filtrate was concentrated 
to yield 106 mg of corysaminium iodide. To a soln. of corysaminium iodide (2 g) in M e O H (300 ml), H C l (35%, 
6 ml) and Zn powder (2 g) were added, and the mixture was kept at 60° for 6 h. After evaporation of the solvent, 
H 2 0 (20 ml) was added and the aq. soln. adjusted to p H ca. 9 (with 28% N H 4 O H soln.) and extracted with 
CHCI3 (2 x 200 ml). The C H C 1 3 layer was dried ( K 2 C 0 3 ) and evaporated to give the mixture (±)-tetrahydro-
corysamine/(±)-mes0-tetrahydrocorysamine as an oil (1.1 g). The oil was chromatographed on a column of silica 
gel (benzene/2-50% gradient Et 2 0) to give (±)-tetrahydrocorysamine (312 mg) and (±)-rae.s0-tetrahydro-
corysamine (409 mg). To a soln. of (±) meso-tetrahydrocorysamine (1 g) in acetone (30 ml), [ 1 3 C]H 3 I (1 g, 99% 
enrichment; Isotec, USA) was added, and the mixture was kept at 80° for 3 h in a sealed tube. After cooling, the 
precipitated crystals were filtered. The crystalline product was recrystallized from M e O H to give f ± J - N -
/(13C)Methyl]-mQso-tetrahydrocorysaminium iodide as orange needles (0.92 g). ! H - N M R (CD 3 OD): 6.931, 6.913 
(q, J = 8.0, each 1 H , H - C ( l l ) , H-C(12)); 6.830, 6.824 (s, each 1 H , H - C ( l ) , H-C(4)); 6.066 (s, O C H 2 0 ) ; 6.022 
(dd, J = 17.5, 1.0, O C H 2 0 ) ; 4.408 (d, J = 9.5, H-C(14)); 3.306 (d, J = 145.0, C(21)H 3); 3.100 (dq, J = 9.5, 6.9, 
H-C(13)); 1.458 (d, J = 6.9, C(22)H 3). 
The iodide (100 mg) was dissolved in M e O H and the soln. chromatographed on a column of an anion-
exchange resin (Amberlite CG-400, type 1, M e O H / H 2 0 ) to give 81 mg of chloride as plates. M.p. 260-270° 
(MeOH/H 2 0) . 
Administration of (±)-N-( 13C-Methyl)-4-Cl {Exper.1). To (±)-( 1 3C-methyl)-4-Cl (80 mg), sterilized H 2 0 
(30 ml) was added, and aliquots of 3 ml of this aq. soln. were poured into 100-ml Erlenmeyer flasks containing 
callus (5 g, 2-weeks old) in Murashige and Skoog's medium (40 ml). The cultures were incubated in the dark on a 
rotary shaker (70 rpm) at 24° for 19 d. The cells and the medium were separated by filtration through a glass filter. 
The medium (40 ml x 10) was adjusted to p H ca. 8 (with 5 % N H 4 O H soln.), and extracted with E t 2 0 (300 ml x 2). 
The E t 2 0 layer was dried ( K 2 C 0 3 ) and evaporated to give a tertiary alkaloid fraction from medium (Fr. M-3). The 
fraction was chromatographed by prep. T L C (MeOH) giving (13C)corycavine (1; 10.1 mg). M.p . 135-136° (Et 2 0), 
[a] D =-160.0 (c = 1.0, CHC1 3). IR: 1668 (C=0). ' H - N M R (CDC1 3): 1.800 (d, J = 124.0, N 1 3 C H 3 ) . M S : 162 
(100), 368 (15, M+). 
The aq. soln. was adjusted to p H ca. 4 (35% H C l soln.), K I (3 g) was added and the soln. extracted with 
CHC1 3 . The CHC1 3 layer was washed with N a 2 S 2 0 3 soln. (10%) and then with sat. NaCl soln., dried (MgS0 4 ) , and 
evaporated in vacuo giving a quaternary-alkaloid fraction from medium (Fr.M-4). This fraction was chro-
matographed on a column of alumina (acetone/MeOH) to give (13C-methyl)-4 iodide (2 mg). [a] D = +87.0 
(c = 0.4, MeOH). 
The cells (fresh weight 80 g) were suspended in M e O H (500 ml) and extracted on a heating bath for 6 h. The 
suspension was filtered and the cells re-extracted in M e O H (2 x 200 ml). The extracts were then combined and 
evaporated in vacuo and the residue was extracted with tartaric-acid soln. (3%, 2 x 150 ml). This acid layer was 
washed with E t 2 0 (2 x 150 ml), and its pH adjusted to ca. 9 (with 15% N H 4 O H soln.). The alkaline soln. was 
extracted with E t 2 0 (2 x 200 ml). The combined E t 2 0 layer was dried ( K 2 C 0 3 ) and evaporated to give an oily 
residue (14 mg, tertiary-alkaloid fraction (Fr. C-3)). This fraction was chromatographed by prep. T L C (benzene/ 
E t 2 0 1:1, and MeOH) to give ,3C-corycavine (1; 0.5 mg), l3C-corynoline (2; 2.0 mg; ' H - N M R (CDC1 3): 2.17 (</, 
J = 140, N 1 3 C H 3 ) ; M S : 43 (100), 368 (18, M+)), and 13C-14-epicorynoline (3; 0.2 mg; ' H - N M R (CDC1 3): 2.47 (d, 
J = 140 Hz, N 1 3 C H 3 ) ; M S : 43 (100), 368 (14, M+)). The quaternary-alkaloid fraction from callus (Fr. C-4) gave 
( 1 3C-methyl)-4I(17.1 mg; [a] D = +146.0 (r = 1.0, MeOH)). 
Administration ofN-(13C-Methyl)-4-Cl {Exper.2). Callus (160 g) was incubated with (±)-JV-( 1 3C-methyl)-
4- CI (160 mg) for 10 d. The cells and medium were treated as described above. From Fr. M-3 and C-3: 13C-cory-
cavine (1; 25.7 mg; [<x]D = -149.0 (c = 1.0, CHC1 3)). 
Preparation of (±)-(22-,3C) Corycavinium Chloride ( (22- 1 3 C)-lcCl) . The corycavine (1) fraction (60 mg) 
obtained from administration experiments with (±)-A^-( l 3C-methyl)-4Cl was dissolved in a mixture of M e O H 
(50 ml) and N a O H soln. (5%, 2 drops) and stirred at 40°. After 1 h, the soln. was evaporated in vacuo, and CHC1 3 
(40 ml) was added. The CHC1 3 layer was washed with sat. NaCl soln., dried (Na 2 S0 4 ) , and evaporated to give 
57 mg of (±)-(22- , 3C)-la, as prisms. M.p. 217.0-218.0° (MeOH). (±)-(22- , 3C)-la was dissolved in sterilized H 2 0 
(30 ml), and the soln. made acidic (with 5% H C l soln.). 
Administration of (±)-(22-13C)-\c (Exper.3). Callus (80 g) was incubated with (±)-(22- 1 3C)-lc-Cl (32 mg) 
for 7 d. The cells and medium were treated as described above. From Fr. M-3 and C-3: l3C-corynoline (2; 2.4 mg; 
[a]D = +80 (c =0.5, CHC1 3)), 13C-14-epicorynoline (3; 1.8 mg; [a] D = +110 (c = 0.20, CHC1 3)). From Fr.M-3: 
l3C-corycavine (1; 8.1 mg; [a] D = -40 (c = 1.0, CHC1 3)). From Fr.C-3: l3C-corycavine (1; 1.5 mg: [a] D = -80 
(c = 0.2, CHC1 3)). 
Administration of (±)-(22-13C)-lc-CI (Exper.4). Callus (80 g) was incubated with (±)-(22- 1 3C)-lc-Cl 
(20 mg) for 12 d. The cells and medium were treated as described above. From Fr. M-3 and C-3:13C-corynoline (2; 
1.1 mg; [a] D = +65.0 (c = 0.2, CHC1 3)), l3C-l4-epicorynoline (3; 1.0 mg; [a] D = +34.0 (c = 0.2, CHC1 3)). 
Atomic coordinates have been deposited at the Cambridge Crystallographic Data Centre. 
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